PORTALBERITA.CO.ID - US food ingredients powerhouse Ingredion has finalized an agreement to purchase its British counterpart, Tate & Lyle, for a substantial sum of £2.7 billion (approximately $3.6 billion). This significant corporate buyout, reported by The Guardian, is set to reshape the global ingredients landscape.
The transaction values the London-listed FTSE 250 company at 615 pence per share, representing a notable 60% premium over its share price before acquisition discussions were made public. This move underscores a major consolidation within the specialty ingredients market.
The combined entities have indicated that the integration process will likely involve workforce restructuring as they seek operational efficiencies. Specifically, the companies disclosed that this streamlining could result in a headcount reduction amounting to about 3% of the total workforce, translating to roughly 475 job losses across their merged international operations.
Regarding the anticipated job cuts, the companies issued a joint statement clarifying the rationale: "Any such workforce reduction would be implemented with the aim of combining the strengths and capabilities of both businesses." This action is positioned as necessary for maximizing synergies following the merger.
Tate & Lyle, which maintains a global staff of nearly 5,000 employees, has seen its stock value decline by 50% over the past five years, partly due to lukewarm investor reception despite broader market trends. The British firm currently employs around 200 staff members in the United Kingdom, primarily based at its corporate headquarters in London.
Ingredion, headquartered in Chicago, contributes approximately 11,000 international employees to the new structure, bringing significant scale to the deal finalized on June 8, 2026. This acquisition follows Tate & Lyle’s strategic pivot away from its traditional sugar business.
Historically, the British firm divested its namesake sugar unit to American Sugar Refining for £211 million back in 2010, shifting focus toward artificial sweeteners and specialized components, including the acquisition of CP Kelco in 2024 for $1.8 billion.
Financial forecasts provided by Ingredion suggest the newly integrated corporation is projected to achieve annual revenues nearing $9.9 billion, coupled with adjusted profits estimated at $1.8 billion. This transaction marks another prominent UK-listed company moving into private ownership following recent buyouts of firms like Schroders and Beazley.
David Hearn, Chair of Tate & Lyle, expressed confidence in the strategic value of the merger, stating, "Any such workforce reduction would be implemented with the aim of combining the strengths and capabilities of both businesses." The leadership emphasized that integrating resources will bolster research and global reach.
